Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Highlight articles
Nuclear medicine
Radiochemistry
Radiopharmaceutical sciences
Radiopharmacy
Trends in radiopharmaceutical sciences
Journal
EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628
Informations de publication
Date de publication:
27 Oct 2023
27 Oct 2023
Historique:
received:
04
10
2023
accepted:
13
10
2023
medline:
27
10
2023
pubmed:
27
10
2023
entrez:
27
10
2023
Statut:
epublish
Résumé
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Sections du résumé
BACKGROUND
BACKGROUND
The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
MAIN BODY
METHODS
This selection of highlights provides commentary on 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.
CONCLUSION
CONCLUSIONS
Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Identifiants
pubmed: 37889361
doi: 10.1186/s41181-023-00218-y
pii: 10.1186/s41181-023-00218-y
pmc: PMC10611660
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
35Informations de copyright
© 2023. The Author(s).
Références
EJNMMI Radiopharm Chem. 2023 Jun 30;8(1):13
pubmed: 37389800
Int J Pharm. 2022 Nov 25;628:122345
pubmed: 36349611
J Am Chem Soc. 2023 Aug 16;145(32):17632-17642
pubmed: 37535945
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845
pubmed: 37246997
EPJ Tech Instrum. 2023;10(1):1
pubmed: 36817092
EJNMMI Radiopharm Chem. 2022 Sep 6;7(1):23
pubmed: 36068452
J Nucl Med. 2010 Apr;51(4):13N-6N
pubmed: 20351346
Angew Chem Int Ed Engl. 2023 Sep 4;62(36):e202306654
pubmed: 37439488
Mol Pharm. 2023 Jul 3;20(7):3529-3538
pubmed: 37243620
J Nucl Med. 2017 Sep;58(Suppl 2):61S-66S
pubmed: 28864614
Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1919-1930
pubmed: 31134301
Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3181-3184
pubmed: 37436459
Cell. 2023 Aug 3;186(16):3350-3367.e19
pubmed: 37421950
J Nucl Med. 2022 Apr;63(4):500-510
pubmed: 34740952
Pharmaceutics. 2023 Mar 09;15(3):
pubmed: 36986746
EJNMMI Radiopharm Chem. 2023 May 5;8(1):9
pubmed: 37147500
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1595-1606
pubmed: 34837103
Biomolecules. 2023 Apr 14;13(4):
pubmed: 37189421
Chem Sci. 2023 Apr 17;14(19):5038-5050
pubmed: 37206398
Pharmaceutics. 2022 May 15;14(5):
pubmed: 35631646
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4110-4111
pubmed: 37452871
J Am Chem Soc. 2023 Jul 26;145(29):16261-16270
pubmed: 37434328
Radiology. 1960 Sep;75:465-6
pubmed: 13785827
J Med Chem. 2023 Jul 27;66(14):9561-9576
pubmed: 37199108
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1113-1126
pubmed: 34625828
Prostate Cancer Prostatic Dis. 2021 Sep;24(3):880-890
pubmed: 33746213
Pharmaceuticals (Basel). 2023 Feb 17;16(2):
pubmed: 37259458
Medchemcomm. 2018 Feb 1;9(3):454-459
pubmed: 30108935
Front Chem. 2023 Apr 26;11:1167783
pubmed: 37179772
Eur J Nucl Med. 1995 Jul;22(7):608-16
pubmed: 7498221
J Natl Compr Canc Netw. 2023 Jan;21(1):43-50.e2
pubmed: 36634610
Nucl Med Biol. 2023 May-Jun;120-121:108337
pubmed: 37030076
EJNMMI Radiopharm Chem. 2021 Dec 20;6(1):38
pubmed: 34928478
Cancers (Basel). 2021 Apr 22;13(9):
pubmed: 33921956
J Nucl Med. 2023 Oct;64(10):1516-1518
pubmed: 37591546
Clin Cancer Res. 2015 Nov 1;21(21):4774-9
pubmed: 26373573
Nucl Med Biol. 2023 Jan-Feb;116-117:108310
pubmed: 36565646
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1095-1098
pubmed: 35050391
J Nucl Med. 2021 Oct;62(10):1391-1397
pubmed: 33547209
J Nucl Med. 2009 Jul;50(7):13N-14N
pubmed: 19652219
J Control Release. 2021 Nov 10;339:259-273
pubmed: 34597747
J Med Econ. 2023 Jan-Dec;26(1):366-375
pubmed: 36905581
J Nucl Med. 2023 Aug;64(8):1326
pubmed: 37348920
Nucl Med Biol. 2023 Mar-Apr;118-119:108333
pubmed: 36940567
Eur J Med Chem. 2023 Jan 15;246:114991
pubmed: 36493618
Cancers (Basel). 2023 Jun 11;15(12):
pubmed: 37370758